161 related articles for article (PubMed ID: 22718130)
1. Anti-protective antigen IgG enzyme-linked immunosorbent assay for diagnosis of cutaneous anthrax in India.
Ghosh N; Goel AK
Clin Vaccine Immunol; 2012 Aug; 19(8):1238-42. PubMed ID: 22718130
[TBL] [Abstract][Full Text] [Related]
2. Serodiagnosis of human cutaneous anthrax in India using an indirect anti-lethal factor IgG enzyme-linked immunosorbent assay.
Ghosh N; Tomar I; Lukka H; Goel AK
Clin Vaccine Immunol; 2013 Feb; 20(2):282-6. PubMed ID: 23269414
[TBL] [Abstract][Full Text] [Related]
3. An ELISA using a recombinant chimera of protective antigen and lethal factor for serodiagnosis of cutaneous anthrax in India.
Varshney A; Puranik N; Kumar M; Pal V; Padmaja J; Goel AK
Biologicals; 2019 Jan; 57():55-60. PubMed ID: 30635155
[TBL] [Abstract][Full Text] [Related]
4. A field usable qualitative anti-protective antigen enzyme-linked immunosorbent assay for serodiagnosis of human anthrax.
Ghosh N; Tomar I; Goel AK
Microbiol Immunol; 2013 Feb; 57(2):145-9. PubMed ID: 23252995
[TBL] [Abstract][Full Text] [Related]
5. Development & validation of a quantitative anti-protective antigen IgG enzyme linked immunosorbent assay for serodiagnosis of cutaneous anthrax.
Ghosh N; Gunti D; Lukka H; Reddy BR; Padmaja J; Goel AK
Indian J Med Res; 2015 Aug; 142(2):196-204. PubMed ID: 26354217
[TBL] [Abstract][Full Text] [Related]
6. Specific, sensitive, and quantitative enzyme-linked immunosorbent assay for human immunoglobulin G antibodies to anthrax toxin protective antigen.
Quinn CP; Semenova VA; Elie CM; Romero-Steiner S; Greene C; Li H; Stamey K; Steward-Clark E; Schmidt DS; Mothershed E; Pruckler J; Schwartz S; Benson RF; Helsel LO; Holder PF; Johnson SE; Kellum M; Messmer T; Thacker WL; Besser L; Plikaytis BD; Taylor TH; Freeman AE; Wallace KJ; Dull P; Sejvar J; Bruce E; Moreno R; Schuchat A; Lingappa JR; Martin SK; Walls J; Bronsdon M; Carlone GM; Bajani-Ari M; Ashford DA; Stephens DS; Perkins BA
Emerg Infect Dis; 2002 Oct; 8(10):1103-10. PubMed ID: 12396924
[TBL] [Abstract][Full Text] [Related]
7. Rapid, sensitive, and specific lateral-flow immunochromatographic device to measure anti-anthrax protective antigen immunoglobulin g in serum and whole blood.
Biagini RE; Sammons DL; Smith JP; MacKenzie BA; Striley CA; Snawder JE; Robertson SA; Quinn CP
Clin Vaccine Immunol; 2006 May; 13(5):541-6. PubMed ID: 16682473
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of clinical and serological findings for diagnosis of cutaneous anthrax infection after an outbreak.
Gulseren D; Süzük-Yıldız S; Çelebi B; Kılıç S
Cutan Ocul Toxicol; 2017 Sep; 36(3):289-293. PubMed ID: 28076993
[TBL] [Abstract][Full Text] [Related]
9. Comparison of a multiplexed fluorescent covalent microsphere immunoassay and an enzyme-linked immunosorbent assay for measurement of human immunoglobulin G antibodies to anthrax toxins.
Biagini RE; Sammons DL; Smith JP; MacKenzie BA; Striley CA; Semenova V; Steward-Clark E; Stamey K; Freeman AE; Quinn CP; Snawder JE
Clin Diagn Lab Immunol; 2004 Jan; 11(1):50-5. PubMed ID: 14715544
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of serologic tests for diagnosis of anthrax after an outbreak of cutaneous anthrax in Paraguay.
Harrison LH; Ezzell JW; Abshire TG; Kidd S; Kaufmann AF
J Infect Dis; 1989 Oct; 160(4):706-10. PubMed ID: 2507648
[TBL] [Abstract][Full Text] [Related]
11. Quantitative assessment of anthrax vaccine immunogenicity using the dried blood spot matrix.
Schiffer JM; Maniatis P; Garza I; Steward-Clark E; Korman LT; Pittman PR; Mei JV; Quinn CP
Biologicals; 2013 Mar; 41(2):98-103. PubMed ID: 23266055
[TBL] [Abstract][Full Text] [Related]
12. Development and application of a Bacillus anthracis protective antigen domain-1 in-house ELISA for the detection of anti-protective antigen antibodies in cattle in Zambia.
Simbotwe M; Fujikura D; Ohnuma M; Omori R; Furuta Y; Muuka GM; Hang'ombe BM; Higashi H
PLoS One; 2018; 13(10):e0205986. PubMed ID: 30335853
[TBL] [Abstract][Full Text] [Related]
13. Immune responses to Bacillus anthracis protective antigen in patients with bioterrorism-related cutaneous or inhalation anthrax.
Quinn CP; Dull PM; Semenova V; Li H; Crotty S; Taylor TH; Steward-Clark E; Stamey KL; Schmidt DS; Stinson KW; Freeman AE; Elie CM; Martin SK; Greene C; Aubert RD; Glidewell J; Perkins BA; Ahmed R; Stephens DS
J Infect Dis; 2004 Oct; 190(7):1228-36. PubMed ID: 15346332
[TBL] [Abstract][Full Text] [Related]
14. The early humoral immune response to Bacillus anthracis toxins in patients infected with cutaneous anthrax.
Brenneman KE; Doganay M; Akmal A; Goldman S; Galloway DR; Mateczun AJ; Cross AS; Baillie LW
FEMS Immunol Med Microbiol; 2011 Jul; 62(2):164-72. PubMed ID: 21401726
[TBL] [Abstract][Full Text] [Related]
15. Serological studies of patients with cutaneous and oral-oropharyngeal anthrax from northern Thailand.
Sirisanthana T; Nelson KE; Ezzell JW; Abshire TG
Am J Trop Med Hyg; 1988 Dec; 39(6):575-81. PubMed ID: 3144920
[TBL] [Abstract][Full Text] [Related]
16. Identification of Bacillus anthracis by a simple protective antigen-specific mAb dot-ELISA.
Sastry KSR; Tuteja U; Santhosh PK; Lalitha MK; Batra HV
J Med Microbiol; 2003 Jan; 52(Pt 1):47-49. PubMed ID: 12488565
[TBL] [Abstract][Full Text] [Related]
17. Validation and long term performance characteristics of a quantitative enzyme linked immunosorbent assay (ELISA) for human anti-PA IgG.
Semenova VA; Schiffer J; Steward-Clark E; Soroka S; Schmidt DS; Brawner MM; Lyde F; Thompson R; Brown N; Foster L; Fox S; Patel N; Freeman AE; Quinn CP
J Immunol Methods; 2012 Feb; 376(1-2):97-107. PubMed ID: 22197974
[TBL] [Abstract][Full Text] [Related]
18. An enzyme-linked immunosorbent assay for detecting anthrax antibody in white-tailed deer (Odocoileus virginianus): evaluation of anthrax vaccination and sera from free-ranging deer.
Peterson MJ; Davis DS; Templeton JW
J Wildl Dis; 1993 Jan; 29(1):130-5. PubMed ID: 8445773
[TBL] [Abstract][Full Text] [Related]
19. Validation of high throughput screening of human sera for detection of anti-PA IgG by Enzyme-Linked Immunosorbent Assay (ELISA) as an emergency response to an anthrax incident.
Semenova VA; Steward-Clark E; Maniatis P; Epperson M; Sabnis A; Schiffer J
Biologicals; 2017 Jan; 45():61-68. PubMed ID: 27814939
[TBL] [Abstract][Full Text] [Related]
20. Development of antibodies to protective antigen and lethal factor components of anthrax toxin in humans and guinea pigs and their relevance to protective immunity.
Turnbull PC; Broster MG; Carman JA; Manchee RJ; Melling J
Infect Immun; 1986 May; 52(2):356-63. PubMed ID: 3084381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
